Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Ovid Therapeutics (OVID) Return on Assets (2020 - 2025)

Ovid Therapeutics (OVID) has disclosed Return on Assets for 6 consecutive years, with 0.51% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Assets fell 22.0% year-over-year to 0.51%, compared with a TTM value of 0.51% through Sep 2025, down 22.0%, and an annual FY2024 reading of 0.22%, up 13.0% over the prior year.
  • Return on Assets was 0.51% for Q3 2025 at Ovid Therapeutics, down from 0.48% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.73% in Q1 2021 and bottomed at 0.51% in Q3 2025.
  • Average Return on Assets over 5 years is 0.15%, with a median of 0.34% recorded in 2023.
  • The sharpest move saw Return on Assets skyrocketed 158bps in 2021, then crashed -109bps in 2022.
  • Year by year, Return on Assets stood at 0.61% in 2021, then tumbled by -155bps to 0.34% in 2022, then fell by -15bps to 0.39% in 2023, then skyrocketed by 30bps to 0.27% in 2024, then plummeted by -90bps to 0.51% in 2025.
  • Business Quant data shows Return on Assets for OVID at 0.51% in Q3 2025, 0.48% in Q2 2025, and 0.29% in Q1 2025.